{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:57:59Z","timestamp":1784030279540,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006342","name":"Association Vaincre la Mucoviscidose","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jcf.2023.10.011","type":"journal-article","created":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T07:53:40Z","timestamp":1698566020000},"page":"579-586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prevalence and severity of functional urinary and anorectal disorders and their impact on quality of life in cystic fibrosis"],"prefix":"10.1016","volume":"23","author":[{"given":"Katelyne","family":"Hubeaux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Gueganton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Arnouat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Belleguic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Danner-Boucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Mankikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Payet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Buyse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9195-2183","authenticated-orcid":false,"given":"Sophie","family":"Ramel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2023.10.011_bib0001","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1464-410X.2003.04609.x","article-title":"The prevalence of urinary incontinence in women in four European countries","volume":"93","author":"Hunskaar","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.jcf.2023.10.011_bib0002","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1471-0528.2005.00763.x","article-title":"Mode of delivery and severe stress incontinence. A cross-sectional study among 2,625 perimenopausal women","volume":"112","author":"Fritel","year":"2005","journal-title":"BJOG"},{"issue":"Suppl 45","key":"10.1016\/j.jcf.2023.10.011_bib0003","first-page":"28","article-title":"Urinary incontinence in cystic fibrosis","volume":"98","author":"Dodd","year":"2005","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jcf.2023.10.011_bib0004","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/resp.13125","article-title":"A systematic review of the prevalence and impact of urinary incontinence in cystic fibrosis","volume":"23","author":"Frayman","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.jcf.2023.10.011_bib0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcf.2008.09.002","article-title":"Urinary incontinence in 9-16 year olds with cystic fibrosis compared to other respiratory conditions and a normal group","volume":"8","author":"Browne","year":"2009","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.10.011_bib0006","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jpurol.2004.07.001","article-title":"The prevalence of stress urinary incontinence in patients with cystic fibrosis: an under-recognized problem","volume":"1","author":"Blackwell","year":"2005","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.jcf.2023.10.011_bib0007","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1742-1241.2003.tb10460.x","article-title":"Incontinence in adult females with cystic fibrosis: a Northern Ireland survey","volume":"57","author":"Moran","year":"2003","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jcf.2023.10.011_bib0008","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s10620-017-4825-2","article-title":"Prevalence of fecal incontinence in adults with cystic fibrosis","volume":"63","author":"Benezech","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jcf.2023.10.011_bib0009","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.urology.2007.11.100","article-title":"Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the Urinary Symptom Profile (USP) questionnaire","volume":"71","author":"Haab","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.jcf.2023.10.011_bib0010","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.juro.2008.08.016","article-title":"Development and validation of the short form of a urinary quality of life questionnaire: sF-Qualiveen","volume":"180","author":"Bonniaud","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.jcf.2023.10.011_bib0011","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02050307","article-title":"Etiology and management of fecal incontinence","volume":"36","author":"Jorge","year":"1993","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.jcf.2023.10.011_bib0012","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1022037320039","article-title":"Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients","volume":"12","author":"Henry","year":"2003","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jcf.2023.10.011_bib0013","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s00192-019-03945-6","article-title":"Strong agreement between interview-obtained and self-administered Wexner and St. Mark's scores using a single questionnaire","volume":"30","author":"Norderval","year":"2019","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.jcf.2023.10.011_bib0014","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3109\/21681805.2015.1096826","article-title":"Urinary incontinence in patients with cystic fibrosis","volume":"50","author":"Reichman","year":"2016","journal-title":"Scand J Urol"},{"key":"10.1016\/j.jcf.2023.10.011_bib0015","doi-asserted-by":"crossref","unstructured":"Hannestad Y.S., Rortveit G., Sandvik H., Hunskaar S., Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Tr\u00f8ndelag. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Tr\u00f8ndelag. J Clin Epidemiol 2000;53:1150\u20137. 10.1016\/s0895-4356(00)00232-8.","DOI":"10.1016\/S0895-4356(00)00232-8"},{"key":"10.1016\/j.jcf.2023.10.011_bib0016","unstructured":"Protocole National de Diagnostic et de Soins (PNDS) Mucoviscidose (HAS, 2017), n.d."},{"key":"10.1016\/j.jcf.2023.10.011_bib0017","article-title":"The prevalence and severity of symptoms of incontinence in adult cystic fibrosis patients","author":"White","year":"2009","journal-title":"Physiother Theory Pract"},{"key":"10.1016\/j.jcf.2023.10.011_bib0018","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ppul.25723","article-title":"Prevalence and factors associated with urinary incontinence in females with cystic fibrosis: an Italian single-center cross-sectional analysis","volume":"57","author":"Mariani","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2023.10.011_bib0019","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.physio.2014.11.001","article-title":"Prevalence and impact of urinary incontinence in men with cystic fibrosis","volume":"101","author":"Burge","year":"2015","journal-title":"Physiotherapy"},{"key":"10.1016\/j.jcf.2023.10.011_bib0020","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1136\/bmj.322.7301.1521","article-title":"Questionnaire survey of urinary incontinence in women with cystic fibrosis","volume":"322","author":"Orr","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.jcf.2023.10.011_bib0021","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0399-8320(06)73076-7","article-title":"Prevalence of anal incontinence in adults and impact on quality-of-life","volume":"30","author":"Damon","year":"2006","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.jcf.2023.10.011_bib0022","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00192-016-3152-z","article-title":"Prevalence and impact of pelvic floor dysfunction in an adult cystic fibrosis population: a questionnaire survey","volume":"28","author":"Chambers","year":"2017","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.jcf.2023.10.011_bib0023","doi-asserted-by":"crossref","DOI":"10.1007\/s10620-022-07812-1","article-title":"Cystic fibrosis-related gut dysbiosis: a systematic review","author":"Caley","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jcf.2023.10.011_bib0024","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.eururo.2017.12.031","article-title":"EAU guidelines on assessment and nonsurgical management of urinary incontinence","volume":"73","author":"Nambiar","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.jcf.2023.10.011_bib0025","article-title":"Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women","volume":"10","author":"Dumoulin","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2023.10.011_bib0026","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eururo.2022.01.045","article-title":"European association of urology guidelines on the diagnosis and management of female non-neurogenic lower urinary tract symptoms. part 1: diagnostics, overactive bladder, stress urinary incontinence, and mixed urinary incontinence","volume":"82","author":"Nambiar","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.jcf.2023.10.011_bib0027","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00192-019-04067-9","article-title":"Childbirth after mid-urethral sling surgery: effects on long-term success and complications","volume":"31","author":"Dyrkorn","year":"2020","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.jcf.2023.10.011_bib0028","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pharmthera.2018.04.010","article-title":"Basic and clinical aspects of antimuscarinic agents used to treat overactive bladder","volume":"189","author":"Yamada","year":"2018","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jcf.2023.10.011_bib0029","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1164\/rccm.202011-4153OC","article-title":"Rapid improvement after starting elexacaftor-tezacaftor-ivacaftor in patients with cystic fibrosis and advanced pulmonary disease","volume":"204","author":"Burgel","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2023.10.011_bib0030","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cells11111769","article-title":"CFTR modulators in people with cystic fibrosis: real-world evidence in France","volume":"11","author":"Regard","year":"2022","journal-title":"Cells"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323016594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323016594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:32:21Z","timestamp":1777649541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199323016594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1569199323016594"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2023.10.011","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and severity of functional urinary and anorectal disorders and their impact on quality of life in cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2023.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}